Results 321 to 330 of about 3,310,854 (363)
Some of the next articles are maybe not open access.
, 1941
Studies of the permeability and absorptivity of the skin have engaged the interest of dermatologists from time to time, because since ancient days the management of most cutaneous diseases has been dependent in a large part on local and topical treatment.
W. W. Duemling
semanticscholar +1 more source
Studies of the permeability and absorptivity of the skin have engaged the interest of dermatologists from time to time, because since ancient days the management of most cutaneous diseases has been dependent in a large part on local and topical treatment.
W. W. Duemling
semanticscholar +1 more source
Dermatologic Surgery, 2019
BACKGROUND Bleeding is an unavoidable risk of dermatologic surgery. The risk may be higher in patients taking agents that affect hemostasis. OBJECTIVE The aim of this study was to provide an updated review of current anticoagulant and antiplatelet ...
S. Iyengar +3 more
semanticscholar +1 more source
BACKGROUND Bleeding is an unavoidable risk of dermatologic surgery. The risk may be higher in patients taking agents that affect hemostasis. OBJECTIVE The aim of this study was to provide an updated review of current anticoagulant and antiplatelet ...
S. Iyengar +3 more
semanticscholar +1 more source
Psychoactive Agents in Dermatology
2000In dermatology, almost all diseases can benefit from use of psychoactive drugs, but, in our opinion, psychotropic agents are more commonly useful in: 1. Psychiatric syndromes with dermatological expression; in particular: Delusion of parasitosis Dermatitis artefacta Neurotic excoriations Trichotillomania Glossodynia ...
E. Panconesi, G. Hautmann
openaire +2 more sources
New antiviral agents for dermatologic disease
Seminars in Cutaneous Medicine and Surgery, 1998The topic of antiviral agents for dermatologic disease is an area that is rapidly changing and expanding as our knowledge of herpes viruses, HIV, and human papilloma viruses continues to expand. New drugs are continuing to make therapy for these viruses more efficacious day by day.
Stephen K. Tyring +2 more
openaire +3 more sources
Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease.
Current Opinion in Gastroenterology, 2019PURPOSE OF REVIEW Dermatologic manifestations in patients with inflammatory bowel disease (IBD) are increasingly recognized as related disorders, secondary to specific therapies used to treat IBD, or complications of IBD itself.
E. Brenner, M. Long
semanticscholar +1 more source
Use of the Newer Immunosuppressive Agents in Dermatology
BioDrugs, 1997Immune mechanisms play a central role in various diseases such as eczema and psoriasis, and in the past treatment tended to involve corticosteroids and cytostatic drugs. Organ transplantation has stimulated the development of newer immunosuppressants, some of which have also been found to be efficacious in the inflammatory dermatoses.
Sakari Reitamo +2 more
openaire +3 more sources
Dermatologic adverse events of checkpoint inhibitors: what an oncologist should know.
Immunotherapy, 2016Immune checkpoint inhibitors (ICI) represent a new revolutionary weapon in the armamentarium of anti-cancer therapies. The side effects of these new agents represent a new challenge for oncologists; they are usually unpredictable and sometimes life ...
Maya Habre, S. B. Habre, H. Kourie
semanticscholar +1 more source
A multi-agent architecture for teaching dermatology
Medical Informatics, 1998This work proposes the integration of computer-aided instruction systems in the curricula of medical education, and describes an intelligent tutoring system used for teaching Dermatology. The Dermatology Tutor uses a self-organized society of autonomous software agents which have different capabilities or roles.
Ioannis D. Zaharakis +2 more
openaire +3 more sources
[Biological dermatologic agents. The Danish Society of Dermatology].
Ugeskrift for laeger, 2007Udgivelsesdato: Mar ...
Iversen, Lars, Kragballe, Knud
openaire +2 more sources
Delayed dermatologic hypersensitivity reaction secondary to ipilimumab.
Journal of immunotherapy, 2015The treatment of melanoma has long favored the use of immunologic agents. Ipilimumab is a monoclonal antibody used to enhance the immune response. This therapy is associated with a variety of adverse reactions including skin reactions.
Steven P. Ludlow, N. Kay
semanticscholar +1 more source